PMID: 9546975Jan 1, 1997Paper

The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease

Vascular Medicine
Alan T HirschD K Hatsukami

Abstract

Despite the widely held belief that there are no effective medical therapies for peripheral arterial disease (PAD), current data suggest that medical therapies can effectively modify the natural history of atherosclerotic lower extremity arterial occlusive disease. The ideal medical therapy would improve claudication, forestall the onset of limb-threatening events, decrease rates of invasive interventional therapies and improve long-term patient survival. These ideal outcomes might be achieved through the use of smoking cessation interventions, including behavioral and pharmacological therapy, and the administration of antiplatelet and lipid-lowering medications in patients with PAD.

References

Apr 1, 1978·The British Journal of Surgery·K A MyersP J Morris
May 27, 1978·British Medical Journal·W G HughsonI Walton
May 27, 1978·British Medical Journal·W G HughsonA Garrod
Nov 1, 1976·American Journal of Surgery·F F McAllister
Aug 22, 1991·The New England Journal of Medicine·S R TunisE P Steinberg
May 1, 1991·British Journal of Addiction·H A Lando
Feb 1, 1991·Circulation·D H BlankenhornE C Wickham
Jul 1, 1990·Comprehensive Psychiatry·L S CoveyF Stetner
Sep 26, 1990·JAMA : the Journal of the American Medical Association·A H GlassmanJ Johnson
Sep 9, 1989·BMJ : British Medical Journal·S WisemanJ T Powell
Mar 1, 1989·The American Journal of Psychiatry·N B EdwardsT L Rosenthal
Jul 1, 1989·Annals of Vascular Surgery·M D McDaniel, J L Cronenwett
Jan 1, 1989·Annals of Vascular Surgery·F M AmeliR Prosser
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Di Chiara, A Imperato
Dec 1, 1987·Journal of Clinical Psychopharmacology·E M SellersK Kadlec
Nov 1, 1986·British Medical Journal·R JelnesT Schroeder
Jan 1, 1985·Journal of the American Geriatrics Society·W B Kannel, D L McGee
Mar 1, 1982·The British Journal of Surgery·R B KingT J Devine
Feb 1, 1982·Journal of Consulting and Clinical Psychology·S Shiffman
Jun 1, 1982·The British Journal of Surgery·C R Quick, L T Cotton
Aug 1, 1982·Archives of Surgery·C A ClyneA D Chant
Sep 1, 1981·The British Journal of Surgery·R M GreenhalghG W Taylor
Jul 1, 1980·The British Journal of Surgery·R B KingP J Morris
Sep 1, 1994·European Journal of Vascular Surgery·R D SayersP R Bell
Jul 28, 1993·JAMA : the Journal of the American Medical Association·A B NewmanL H Kuller
Jul 28, 1993·JAMA : the Journal of the American Medical Association·M T VogtS B Hulley
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Aug 14, 1996·JAMA : the Journal of the American Medical Association·R F Perry

❮ Previous
Next ❯

Citations

Jan 9, 2003·Expert Opinion on Investigational Drugs·Daniel A DuprezAlan T Hirsch
Apr 21, 2004·Journal of the American Pharmacists Association : JAPhA·J Chris Bradberry
Jun 22, 2005·European Journal of Internal Medicine·Stavros AntonopoulosGregory Giannoulis
Jul 4, 2001·The American Journal of Cardiology·D L Dawson
Jul 4, 2001·The American Journal of Cardiology·A J Comerota
Feb 26, 2004·Journal of Vascular Surgery·Andrew W GardnerLeslie I Katzel
Mar 9, 2010·Journal of Vascular Surgery·Hans C FluJan-Willem H P Lardenoye
Mar 13, 2010·Journal of Vascular Surgery·James H Black
Jan 2, 2007·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·S KhanG Stansby
Feb 28, 2002·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·R Donnelly, J M Yeung
Sep 27, 2003·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·S D Hobbs, A W Bradbury
Jul 20, 2002·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·P BurnsA W Bradbury
Dec 30, 2011·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·N DiehmJ Apelqvist
Apr 20, 2005·Journal of Vascular Surgery·Simon D HobbsAndrew W Bradbury
Dec 1, 2004·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·S KhanG Stansby
Apr 25, 2006·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·A Gottsäter
Sep 14, 2006·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·A M LazarisP R Bell
Nov 19, 2002·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·P BurnsA W Bradbury
Jan 29, 2002·The American Journal of Medicine·Judith G Regensteiner, William R Hiatt
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·B L W BendermacherM H Prins
Feb 18, 2012·Therapeutic Advances in Cardiovascular Disease·Saurabh AggarwalRohit Arora
Jan 12, 2011·Angiology·Gerard StansbyUNKNOWN Prospective Registry and Evaluation of Peripheral Arterial Risks, Events and Distribution Investigators
Apr 1, 2006·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Renzhe CuiTakashi Shimamoto
Aug 23, 2003·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Anthony J Comerota
Nov 24, 2004·Southern Medical Journal·Jeffrey J FineJ Huger Richardson
Jul 2, 2002·Preventive Cardiology·David L DawsonAlan T Hirsch
Jan 23, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Herbert Aronow
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·E FagliaUNKNOWN SCAR (SCreening for ARteriopathy) Study Group
May 20, 2004·British Journal of Nursing : BJN·Sharon Dorgan
Oct 4, 2019·VASA. Zeitschrift für Gefässkrankheiten·Ulrich FrankJill Belch
Dec 4, 2019·VASA. Zeitschrift für Gefässkrankheiten·Ulrich FrankPiotr Terlecki
May 9, 2001·Current Treatment Options in Cardiovascular Medicine·Alan T. Hirsch, Laura M Reich
Jun 23, 2001·The Journal of Cardiovascular Nursing·S K ChristmanJ Buckworth
Sep 13, 2006·The Journal of Cardiovascular Nursing·Roberta K Oka
Oct 2, 2003·Vascular Medicine·Christian F A Kügler, Gottfried Rudofsky
Dec 29, 2000·Annals of Vascular Surgery·P G KalmanP Ritvo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved